Recall Register

Food, drugs, devices › Terumo Cardiovascular Systems Corporation

Device recall: Terumo Advanced Perfusion System 1 Electronic Patient Gas System Catalog #: 801188

FDA enforcement event 88350 · Class II · initiated 8 Jun 2021 · status Terminated · terminated 28 Jun 2022

DeviceVoluntary: Firm initiated1 product recordAnn Arbor, MI

FDA enforcement event 88350 is a device recall by Terumo Cardiovascular Systems Corporation of Ann Arbor, MI, initiated 8 Jun 2021 and classified Class II, with 1 product record.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 89% of the 900 device enforcement events initiated in 2021 carry the same class.

Status: Terminated, terminated 28 Jun 2022. Initiation: voluntary: firm initiated. Terumo Cardiovascular Systems Corporation has 73 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Terumo Cardiovascular Systems Corporation, Ann Arbor, MI.

Reason for recall

"intermittent failure causes a blender initialization fault upon start-up, or during an EPGS calibration attempt following the 15-minute warm-up period. The control sliders on the Central Control Monitor (CCM) are disabled and the gas system can only be controlled by the local control knobs"

Distribution

"International distribution in the country of Panama."

Product records

Recall numberProductQuantityClassStatusReport date
Z-2350-2021Terumo Advanced Perfusion System 1 Electronic Patient Gas System Catalog #: 8011881 unit OUSClass IITerminated1 Sep 2021

Context

89%of 2021 device events are Class II900 events that year
1product record in this eventfirm median: 2
73events on this register for the firm

Other enforcement events for Terumo Cardiovascular Systems Corporation

InitiatedProduct (first record)TypeClassRecords
28 May 2025CDI OneView System BPM Probe: Cat. No. CDI753 - CDI OneView BPM Probe, Cat. No. CDI753TK - CDI OneView BPM Probe Trial KDeviceClass II1
3 Mar 2025Terumo CDI OneView Monitoring System Hematocrit / Oxygen Saturation Probe, Catalog Number REF CD1754DeviceClass II1
20 Feb 2024Cardiovascular Procedure Kits that include High Crack Check Valve PN 205307A Part Number: 6375 16010 62974 65246 66312 6DeviceClass II1
1 Mar 2023CAPIOX RX15 Hollow Fiber Oxygenator, Catalog Number 3CX*RX15RE30DeviceClass II3
16 Apr 2021The Terumo HX2 Temperature Management System provides temperature control of two independent water circuits that directlDeviceClass II3
2 Mar 2021Consist of a distal connection mechanism (either standard Terumo Ball Quick Connect or Terumo Shaft Quick Connect), an aDeviceClass II1
11 Nov 2020(1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, Sterile Catalog NuDeviceClass II1
25 Aug 2020Terumo Advanced Perfusion System 1 Ultrasonic Air Sensor 3/8x3/32, Catalog Number 5773 - Product Usage: intended for useDeviceClass II3
10 Jan 2020Terumo Advanced Perfusion System 1 Roller Pump, 4 Inch, Catalog Number 816570 - Product Usage: is indicated for use for DeviceClass II4
14 Jun 2019Terumo Capiox NX19 Oxygenator With Reservoir (East Orientation) P/N: 3CX*NX19REDeviceClass II4

All 73 events for Terumo Cardiovascular Systems Corporation

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "intermittent failure causes a blender initialization fault upon start-up, or during an EPGS calibration attempt following the 15-minute warm-up period. The control sliders on the Central Control Monitor (CCM) are disabled and the gas system can only be controlled by the local control knobs"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "International distribution in the country of Panama."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 28 Jun 2022. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.